Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of the American Chemical Society
|
January 18, 2007
Enantioselective synthesis and structure revision of solandelactone E
Jennifer E Davoren, Stephen F Martin
The Journal of Organic Chemistry
|
December 20, 2007
Studies toward the enantioselective syntheses of oxylipins: total synthesis and structure revision of solandelactone E
Jennifer E Davoren, Christian Harcken, Stephen F Martin
Accounts of Chemical Research
|
January 16, 2008
Targeting mitochondria
Adam T Hoye, Jennifer E Davoren, Peter Wipf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2008
An experimental survey of the transition between two-state and downhill protein folding scenarios
Feng Liu, Deguo Du, Amelia A Fuller, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Measurement of atropisomer racemization kinetics using segmented flow technology
Jennifer E Davoren, Mark W Bundesmann, Qi T Yan, et al.
Molecular Pharmacology
|
July 7, 2016
Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284
Deborah L Smith, Jennifer E Davoren, Jeremy R Edgerton, et al.
Biochemistry
|
December 14, 2016
Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M<sub>1</sub> Receptor Activation
Michael Popiolek, David P Nguyen, Veronica Reinhart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2009
Evaluating beta-turn mimics as beta-sheet folding nucleators
Amelia A Fuller, Deguo Du, Feng Liu, et al.
Journal of Medicinal Chemistry
|
November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization
Jennifer E Davoren, Deane Nason, Jotham Coe, et al.
Frontiers in Pharmacology
|
August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
Rouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of the American Chemical Society
|
January 18, 2007
Enantioselective synthesis and structure revision of solandelactone E
Jennifer E Davoren, Stephen F Martin
The Journal of Organic Chemistry
|
December 20, 2007
Studies toward the enantioselective syntheses of oxylipins: total synthesis and structure revision of solandelactone E
Jennifer E Davoren, Christian Harcken, Stephen F Martin
Accounts of Chemical Research
|
January 16, 2008
Targeting mitochondria
Adam T Hoye, Jennifer E Davoren, Peter Wipf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2008
An experimental survey of the transition between two-state and downhill protein folding scenarios
Feng Liu, Deguo Du, Amelia A Fuller, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Measurement of atropisomer racemization kinetics using segmented flow technology
Jennifer E Davoren, Mark W Bundesmann, Qi T Yan, et al.
Molecular Pharmacology
|
July 7, 2016
Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284
Deborah L Smith, Jennifer E Davoren, Jeremy R Edgerton, et al.
Biochemistry
|
December 14, 2016
Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M<sub>1</sub> Receptor Activation
Michael Popiolek, David P Nguyen, Veronica Reinhart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2009
Evaluating beta-turn mimics as beta-sheet folding nucleators
Amelia A Fuller, Deguo Du, Feng Liu, et al.
Journal of Medicinal Chemistry
|
November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization
Jennifer E Davoren, Deane Nason, Jotham Coe, et al.
Frontiers in Pharmacology
|
August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
Rouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
Page
of 2